Intelligent device with artificial intelligence for monitoring neuropathic pain
An AI-driven neuropathic pain monitoring device with integrated sensors and neuromodulation therapy addresses the limitations of current solutions by providing continuous, objective monitoring and personalized treatment, enhancing pain management efficacy.
Patent Information
- Application Number
- DE202024105231
- Authority / Receiving Office
- DE · DE
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-12-05
- Estimated Expiration
- 2034-09-30
AI Technical Summary
Current solutions for neuropathic pain management are largely reactive, rely on subjective patient reports, and lack continuous, objective monitoring, leading to inconsistent treatment outcomes and significant side effects from pharmacological and invasive interventions.
An intelligent AI-based device integrating advanced sensors, a neural processing unit, and machine learning to continuously monitor physiological data, providing personalized pain management through real-time analysis and targeted neuromodulation therapy.
Enables accurate, continuous, and personalized pain assessment and treatment, reducing the need for pharmacological interventions and minimizing side effects by offering adaptive, non-invasive pain management.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
Technical area:
[0001] The present invention relates to an intelligent artificial intelligence-based device for monitoring and treating neuropathic pain. More specifically, it is a system that integrates artificial intelligence (AI) techniques, advanced sensors, and a neural processing unit to continuously evaluate and analyze pain signals in patients with neuropathy. The device is intended to provide real-time pain assessments, trend analysis, and personalized pain treatment recommendations, thus improving the effectiveness of pain therapies. Background:
[0002] Neuropathic pain, caused by damage or dysfunction of the nervous system, poses a significant challenge for clinical treatment due to its complexity and variability within each patient. Conventional pain assessment methods often rely on self-report or episodic clinical evaluations, which may not capture the full extent of a patient's pain experience. Furthermore, the subjective nature of pain and its variations due to emotional, psychological, and environmental factors complicate accurate diagnosis and treatment. There is a need for an objective, continuous, and intelligent monitoring system that enables comprehensive pain assessment and assists in the development of personalized pain management strategies.
[0003] Neuropathic pain is a complex, chronic pain condition resulting from nerve damage or dysfunction in the peripheral or central nervous system. This type of pain can have a variety of causes, including diabetes, chemotherapy, physical injury, or medical conditions such as multiple sclerosis and shingles. Patients often describe neuropathic pain as stabbing or burning pain and may be accompanied by tingling or numbness. Unlike nociceptive pain, which is caused by an immediate injury or tissue damage and is usually short-lived, neuropathic pain is persistent and can significantly impact a patient's quality of life. Treating neuropathic pain is challenging due to its chronic nature and the varying presentations it presents in different patients.
[0004] Existing solutions for treating neuropathic pain primarily include pharmacological treatments, interventional procedures, and non-pharmacological therapies. Pharmacological treatments such as antiepileptic drugs (e.g., gabapentin, pregabalin) and antidepressants (e.g., amitriptyline, duloxetine) often represent the first line of therapy. These medications work by altering neurotransmitter levels or neuronal activity patterns, potentially reducing pain sensation. However, pharmacological treatments have significant drawbacks. Many patients experience only partial relief, and the medications can have serious side effects, including sedation, dizziness, cognitive impairment, and an increased risk of falls, particularly in the elderly.Long-term use of these medications can lead to tolerance and dependence, requiring higher doses for the same level of pain relief, which in turn worsens side effects. Furthermore, these medications often require a trial-and-error approach to find the right combination and dosage, delaying effective pain management.
[0005] Interventional procedures such as nerve blocks, epidural steroid injections, and radiofrequency ablation offer another approach to treating neuropathic pain. These procedures are typically considered when pharmacological treatments are ineffective or intolerable. Nerve blocks and steroid injections can provide temporary relief by numbing nerves or reducing inflammation, while radiofrequency ablation uses heat to interrupt nerve function and reduce pain signals. However, these procedures are invasive, expensive, and not without risks. They must be performed by a trained specialist, are often associated with discomfort or pain during the procedure, and can lead to complications such as infection, bleeding, or nerve damage.Furthermore, the relief provided by these procedures is usually temporary, necessitating repeated interventions and increasing the cumulative risk to the patient.
[0006] Non-pharmacological therapies such as physical therapy, acupuncture, and cognitive behavioral therapy (CBT) are also used to treat neuropathic pain. Physical therapy aims to improve strength and mobility, which may alleviate some of the functional impairments associated with chronic pain, while acupuncture is thought to stimulate nerve endings and alter pain perception pathways. Cognitive behavioral therapy focuses on modifying the patient's emotional response to pain and developing coping skills. Although these therapies can provide some relief, they are often used as an adjunct to medications or interventional procedures rather than as a standalone treatment. Their effectiveness varies considerably from person to person, and their effect on severe neuropathic pain is often limited.In addition, these therapies require regular patient attendance and active participation, which can be challenging for people with severe pain or limited mobility.
[0007] While existing solutions provide some degree of pain relief, they are largely reactive and focus on alleviating symptoms rather than addressing the underlying neural dysfunction. Furthermore, these approaches rely heavily on patients' subjective reports of pain, which can be influenced by various factors, including emotional state, cognitive biases, and communication skills. The subjective nature of pain assessment poses a significant challenge to accurate diagnosis and effective treatment, leading to inconsistent treatment outcomes. Therefore, there is a critical need for more objective, continuous monitoring solutions that provide real-time insights into a patient's pain experience and enable more targeted, individualized interventions.
[0008] In recent years, technological advances have led to the development of various pain management devices, such as spinal cord stimulators (SCSs) and peripheral nerve stimulators (PNSs). These devices deliver electrical impulses to specific nerves or the spinal cord to interrupt pain signals before they reach the brain. While effective in some cases, these devices are invasive and require surgical implantation. They also carry risks such as infection, device malfunction, and nerve damage. The need for surgery and the potential for complications make these options less desirable for many patients, particularly older patients or those with comorbidities that increase the risk of surgery.
[0009] There have also been attempts to develop wearable devices for pain management, such as transcutaneous electrical nerve stimulation (TENS) devices. TENS devices deliver low-voltage currents through the skin to stimulate nerves and reduce pain perception. While TENS therapy is non-invasive and can provide temporary pain relief, its effectiveness varies widely. Some studies show limited benefit, particularly for chronic neuropathic pain. TENS devices also lack the ability to adapt to the user's specific pain patterns or provide continuous monitoring, limiting their usefulness as a comprehensive pain management solution.
[0010] Despite these advances, most current devices and solutions are not well integrated with emerging technologies such as artificial intelligence (AI) and machine learning, which hold promise for improving pain management outcomes. AI and machine learning techniques can analyze large data sets to identify patterns and predict pain episodes, offering the potential for more personalized and proactive pain management strategies. However, the integration of AI into pain management devices is limited, and there are currently no commercially available devices that fully utilize AI's capabilities to provide continuous, real-time pain assessment and adaptive interventions.
[0011] The present invention addresses these gaps in existing solutions by providing an intelligent AI-based neuropathic pain monitoring device that integrates advanced sensor technology, machine learning techniques, and neuromodulation therapy into a single wearable platform. Unlike existing solutions that rely on subjective reports and periodic assessments, this device continuously monitors physiological data, including skin conductance, muscle activity, heart rate variability, and skin temperature, that are indicative of pain. By employing a neural processing unit (NPU) specifically designed to execute complex machine learning techniques, the device can analyze this data in real time to detect patterns associated with different types and intensities of neuropathic pain.This approach allows for a more objective assessment of pain and allows the device to provide personalized pain management recommendations tailored to the individual's unique pain profile.
[0012] Furthermore, the invention includes a neuromodulation actuator that can deliver targeted therapeutic interventions such as transcutaneous electrical nerve stimulation (TENS) or microcurrent therapy based on the detected pain intensity and pattern. This feature enables the device to provide on-demand pain relief without the need for pharmacological intervention, potentially reducing the side effects and risks associated with long-term medication use. The integration of AI-guided pain assessment and neuromodulation therapy in a single device provides a comprehensive, non-invasive solution for continuous pain management, improving both the accuracy of pain detection and the efficacy of interventions.
[0013] Furthermore, the device's ability to transmit data to a mobile application or a cloud-based platform facilitates remote monitoring and analysis by healthcare providers, enabling more proactive and informed decision-making in pain management. This connectivity also enables the aggregation and analysis of data from multiple users, further enhancing the ability of machine learning techniques to refine pain detection and treatment strategies. By harnessing the power of AI and real-time data analytics, the present invention represents a significant advance over existing solutions, providing a more effective, personalized, and adaptive approach to treating neuropathic pain.
[0014] The present invention addresses these limitations by providing an intelligent AI-based device that combines continuous, objective pain monitoring with adaptive machine learning techniques and targeted neuromodulation therapy, thus providing a comprehensive and effective solution for treating neuropathic pain. Summary of the invention:
[0015] The present invention provides an intelligent AI-based neuropathic pain monitoring device that utilizes a combination of biosensors, neural networks, and machine learning techniques to continuously monitor physiological parameters and infer the presence and intensity of neuropathic pain. The device is configured to be worn on the body, for example, on the wrist or as a patch, and is equipped with a range of sensors, including, but not limited to, electrodermal activity (EDA) sensors, electromyography (EMG) sensors, heart rate variability (HRV) monitors, and thermal sensors. The device also includes a neural processing unit that applies advanced AI techniques to analyze the collected data in real time and identify patterns and correlations indicative of neuropathic pain.
[0016] The system also includes a communication module for data transfer to a connected mobile application or cloud platform, where the data is stored, further analyzed, and used to generate comprehensive pain reports and treatment recommendations. The mobile application provides patients and healthcare providers with an intuitive user interface to view pain trends, receive alerts for unusual pain episodes, and adjust pain treatment plans based on real-time data.
[0017] The primary objective of the invention is to provide an intelligent AI-based neuropathic pain monitoring device that enables continuous, real-time assessment of pain levels in patients with neuropathic conditions. The device aims to overcome the limitations of traditional pain assessment methods, which often rely on subjective self-reports and intermittent clinical evaluations, by providing an objective, continuous monitoring solution that captures a comprehensive picture of the patient's pain experience.
[0018] Another goal of the invention is to integrate advanced sensor technology with artificial intelligence (AI) techniques to improve the accuracy and reliability of pain detection and classification. The invention aims to utilize a combination of electrodermal activity (EDA) sensors, electromyography (EMG), heart rate variability (HRV) monitors, and thermal sensors to collect multidimensional physiological data. The device's neural processing unit (NPU) is designed to run machine learning models such as convolutional neural networks (CNNs) and recurrent neural networks (RNNs), which are optimized for detecting patterns indicative of neuropathic pain. By continuously learning from the data, the device is intended to provide personalized pain management recommendations tailored to the individual patient's needs.
[0019] Another objective of the invention is to enable seamless data transfer and communication between the device and external platforms such as mobile applications or cloud-based systems. The invention aims to provide Bluetooth Low Energy (BLE) and Wi-Fi connectivity options to enable real-time data transfer and ensure that pain metrics are easily accessible to both patients and healthcare providers. This connectivity enables visualization of pain data, documentation of pain episodes, and remote monitoring by healthcare providers, thus supporting more proactive and informed decision-making in pain management.
[0020] Furthermore, the invention aims to provide a non-pharmacological treatment option through the integration of an actuator mechanism for neuromodulation therapy. The device is designed for targeted interventions such as transcutaneous electrical nerve stimulation (TENS) or microcurrent therapy, based on real-time analysis of pain intensity and patterns detected by AI techniques. This feature is intended to enable on-demand pain relief, potentially reducing the need for medication and minimizing associated side effects, thereby improving treatment outcomes and patient quality of life.
[0021] Furthermore, an objective of the invention is to ensure that the device is comfortable, portable, and user-friendly, supporting continuous use and compliance with pain monitoring protocols. The invention features an ergonomic structure and uses biocompatible materials to ensure comfort and reduce skin irritation. The device also features an intuitive user interface with a touch-sensitive display and vibration feedback to provide alerts and notifications, thus improving user engagement and compliance.
[0022] Finally, the invention aims to address the need for a comprehensive pain management solution that not only monitors pain but also assists in analyzing long-term pain trends and optimizing treatment strategies. By providing healthcare providers with access to detailed pain data and trends over time, the invention facilitates the identification of pain patterns and the evaluation of treatment efficacy, ultimately contributing to more personalized and effective pain management approaches. With these goals in mind, the invention aims to revolutionize the treatment of neuropathic pain and provide a sophisticated, intelligent solution that improves both patient care and clinical outcomes. SHORT DESCRIPTION OF THE FIGURE
[0023] These and other features, aspects, and advantages of the present invention will become more readily understood when the following detailed description is read in conjunction with the accompanying drawings, in which like characters represent like parts throughout. Fig. Figure 1 shows a block diagram of an intelligent AI-based device for monitoring neuropathic pain.
[0024] Furthermore, those skilled in the art will appreciate that elements in the drawings are shown for convenience and may not necessarily be drawn to scale. For example, the flowcharts illustrate the method by key steps to enhance understanding of aspects of the present disclosure. Furthermore, with respect to device construction, one or more components of the device may have been represented in the drawings by conventional symbols, and the drawing may show only the specific details relevant to understanding embodiments of the present disclosure in order not to clutter the drawings with details that would be readily apparent to those skilled in the art who would benefit from the description herein. Detailed description of the invention:
[0025] To facilitate an understanding of the principles of the invention, reference will now be made to the embodiment illustrated in the drawings and described in specific language. It is to be understood, however, that no limitation on the scope of the invention is intended thereby, since such changes and further modifications of the illustrated system, and such further applications of the principles of the invention as illustrated therein, are contemplated as would normally occur to one skilled in the art to which the invention pertains.
[0026] It will be understood by one skilled in the art that the foregoing general description and the following detailed description are exemplary and explanatory of the invention and are not intended to be limiting thereof.
[0027] References in this specification to "one aspect," "another aspect," or similar language mean that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present disclosure. Therefore, occurrences of the phrase "in one embodiment," "in another embodiment," and similar language throughout this specification may or may not all refer to the same embodiment.
[0028] The terms "comprises," "comprising," or other variations thereof are intended to cover non-exclusive inclusion, such that a process or method comprising a list of steps not only includes those steps, but may also include other steps not expressly listed or inherent in such process or method. Likewise, one or more devices or subsystems or elements or structures or components preceded by "comprises...a" does not preclude, without further limitation, the existence of other devices or other subsystems or other elements or other structures or other components or additional devices or additional subsystems or additional elements or additional structures or additional components.
[0029] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The system, methods, and examples provided herein are for illustrative purposes only and should not be considered limiting.
[0030] Embodiments of the present disclosure will be described in detail below with reference to the accompanying drawings.
[0031] In relation to Fig.is a block diagram of an intelligent AI-based device for monitoring neuropathic pain, comprising: a flexible wearable structure 102 made of biocompatible materials and designed to be continuously worn on a user's body, the device comprising: a sensor array 102(a) integrated into the structure and configured to collect physiological data from the user's body, the sensor array comprising at least an electrodermal activity (EDA) sensor for measuring skin conductance, an electromyography (EMG) sensor for detecting muscle activity, a heart rate variability (HRV) monitor for evaluating autonomic nervous system responses, and a thermal sensor for measuring skin temperature;a neural processing unit (NPU) 104 housed within the wearable structure, the NPU specifically designed to perform machine learning techniques with high efficiency and low power consumption, the NPU configured to execute pre-trained models based on convolutional neural networks (CNNs) and recurrent neural networks (RNNs) that analyze multidimensional sensor data to detect patterns indicative of neuropathic pain intensity and type; a communication module 106 within the wearable structure, including Bluetooth Low Energy (BLE) and Wi-Fi connectivity options to enable seamless transfer of processed data to an external device or cloud-based platform;a power management system 108, including a rechargeable battery integrated into the structure and configured to power the sensor array, the NPU, and the communication module, the battery supporting up to 48 hours of continuous operation on a single charge and rechargeable via an inductive charging pad; and a neuromodulation actuator 110 embedded within the wearable structure and configured to deliver transcutaneous electrical nerve stimulation (TENS) or microcurrent therapy under the control of the AI techniques running on the NPU, the actuator providing on-demand therapeutic intervention based on the detected pain intensity and patterns.
[0032] In one embodiment, the flexible wearable structure 102 further includes an adjustable strap mechanism configured to secure the device to the user's body to ensure optimal skin contact for accurate sensor data acquisition, and the structure is water-resistant to protect the housed components from moisture and daily wear and tear.
[0033] In one embodiment, the neural processing unit (NPU) 104 is further configured to perform adaptive machine learning techniques that continuously learn from the user's physiological data over time, enabling the device to improve the accuracy of pain detection and personalize pain management recommendations tailored to the user's condition.
[0034] In one embodiment, the communication module 106 is configured to transmit processed pain data to a mobile application on a user's smartphone, where the mobile application is programmed to display real-time and historical pain measurements, allow the user to enter additional contextual information, and send alerts to healthcare providers to enable remote monitoring and timely interventions.
[0035] In one embodiment, the power management system 108 further includes an energy-efficient circuit design and low-power AI processing capabilities to maximize battery life, and wherein the device includes an integrated haptic feedback mechanism to provide tactile alerts to the user in response to significant pain events detected by the neural processing unit.
[0036] In one embodiment, the neuromodulation therapy actuator mechanism 110 is further configured to dynamically adjust the intensity and frequency of stimulation based on real-time feedback from the sensors and neural processing unit analysis, thereby providing a personalized therapeutic response tailored to the user's current pain condition.
[0037] In one embodiment, the outer surface of the flexible wearable structure 102 includes a touch-sensitive display configured to provide the user with visual feedback on device status, battery life, connectivity, and real-time alerts on detected pain intensity and recommended interventions.
[0038] In one embodiment, the sensor array 102(a) is modular to allow the addition or replacement of specific sensors tailored to the individual needs of the user or specific neuropathic pain conditions, thereby enhancing the versatility and applicability of the device in various clinical scenarios.
[0039] The intelligent, AI-based neuropathic pain monitoring device is ergonomically designed for comfort and long-term wearability. Constructed of a flexible body made of biocompatible materials, the device houses multiple sensors that continuously collect physiological data relevant for pain assessment. Electrodermal activity (EDA) sensors are used to measure skin conductance, which may indicate sympathetic nervous system activity often associated with pain. Electromyography (EMG) sensors detect muscle activity and spasms, which are common in neuropathic pain conditions. The heart rate variability (HRV) monitor evaluates autonomic nervous system responses, while thermal sensors measure skin temperature, providing additional context for pain assessment.
[0040] The device's communication module is equipped with Bluetooth Low Energy (BLE) and Wi-Fi connectivity options, enabling seamless data transfer to the patient's smartphone or a cloud-based platform. The mobile application acts as a central hub, receiving real-time data from the device, displaying pain metrics, and allowing users to enter additional contextual information, such as pain triggers or medications taken. The cloud platform facilitates long-term data storage and enables healthcare providers to perform longitudinal analysis and trend detection.
[0041] In addition to pain monitoring, the device also features an actuator mechanism that can enable neuromodulation therapy. This actuator mechanism, which can include transcutaneous electrical nerve stimulation (TENS) or microcurrent therapy, is controlled by AI techniques based on the detected pain intensity and pain patterns. By delivering therapeutic interventions on demand, the device offers a proactive approach to pain management, potentially reducing the need for pharmacological treatments and their associated side effects.
[0042] The device is designed as a flexible, wearable band or patch with an adjustable strap for a secure fit. The main body of the device is modular, allowing different sensor types to be integrated and interchanged depending on the specific patient needs or monitoring focus. The housing of the electronic components, including the NPU, sensors, battery, and communication module, is made of a durable, water-resistant material to protect against moisture and daily wear and tear.
[0043] The sensor array is strategically positioned on the inner surface of the device, ensuring optimal contact with the skin for accurate data collection. On the outer surface is a small, touch-sensitive display that provides basic information such as battery status, connectivity, and real-time pain alerts. The device also features a vibration motor that provides haptic feedback for alerts and notifications.
[0044] Power management is a key aspect of the device's design. The device is powered by a rechargeable battery that allows for up to 48 hours of continuous use on a single charge. The device incorporates energy-efficient components and power-saving AI processing to maximize battery life, while an inductive charging pad is included for convenient recharging.
[0045] During operation, the device is worn by the patient continuously or semi-continuously. The sensors collect physiological data in real time, which is then processed by the NPU using AI techniques to determine the presence and intensity of neuropathic pain. Upon detection of significant pain events or changes in pain patterns, the device can alert the patient and transmit data to the mobile application or cloud platform for further analysis and review by healthcare providers.
[0046] The mobile application enables the visualization of pain data and provides both real-time and historical insights into pain trends. Patients can also document pain episodes, triggers, and medication use, creating a comprehensive pain management profile. Healthcare providers can remotely access this data to monitor patient progress, adjust treatment plans, and intervene promptly.
[0047] The intelligent AI-based neuropathic pain monitoring device offers several advantages over existing pain management solutions. It enables continuous, objective monitoring of neuropathic pain and reduces the reliance on subjective self-reports. The integration of AI techniques enables accurate detection and classification of pain patterns, leading to more personalized and effective pain management strategies. Furthermore, the device's ability to deliver neuromodulation therapy offers a non-pharmacological treatment option, potentially improving patient outcomes and quality of life.
[0048] The intelligent AI-based neuropathic pain monitoring device is a sophisticated wearable system that enables continuous, real-time assessment and treatment of pain in patients with neuropathic conditions. The device is made of biocompatible materials and configured as a flexible wearable band or patch that can be worn comfortably and securely on the user's body. Central to the device's operation is a sensor array strategically embedded within the wearable structure, which includes an electrodermal activity (EDA) sensor, an electromyography (EMG) sensor, a heart rate variability (HRV) monitor, and a thermal sensor. These sensors are responsible for collecting a wide range of physiological data directly related to the responses of the autonomic nervous system, muscle activity, and skin conductance, all of which are important indicators of neuropathic pain.The collected data is then forwarded to an embedded neural processing unit (NPU), a specialized hardware component optimized to execute machine learning techniques with high efficiency and low power consumption.
[0049] The NPU is configured to run advanced machine learning models, specifically convolutional neural networks (CNNs) and recurrent neural networks (RNNs), pre-trained on large-scale datasets of physiological parameters associated with various types and intensities of neuropathic pain. CNNs are used to process spatially structured data, such as skin temperature fluctuations and skin conductance levels from the thermal and EDA sensors, while RNNs are used to analyze temporal data sequences, including heart rate variability and electromyography signals, which require understanding patterns over time.The models are designed to detect subtle patterns and correlations within this multidimensional dataset that indicate neuropathic pain episodes, allowing the NPU to classify the intensity and type of pain with high accuracy.
[0050] The machine learning techniques employed by the NPU are not static; they are adaptive and capable of continuous learning. This capability allows the device to personalize pain detection and treatment strategies for each user by refining its techniques based on data continuously collected from the user. The device continuously monitors physiological signals and adjusts its pain classification models in real time, improving its predictive accuracy and sensitivity to the individual's unique pain patterns. This personalized approach ensures that the device provides more accurate and relevant feedback, thus improving pain treatment outcomes.
[0051] In addition to its pain monitoring capabilities, the device incorporates a neuromodulation actuator designed to deliver therapeutic interventions such as transcutaneous electrical nerve stimulation (TENS) or microcurrent therapy directly to the affected area. This actuator is controlled by AI techniques running on the NPU, which determine the optimal timing, intensity, and frequency of stimulation based on real-time analysis of detected pain intensity and patterns. The neuromodulation actuator can dynamically adjust therapeutic interventions based on changes in the user's physiological data, providing a tailored approach to pain relief that addresses the user's immediate needs.
[0052] The device is also equipped with a communications module that includes both Bluetooth Low Energy (BLE) and Wi-Fi connectivity options, enabling seamless data transfer to a mobile application or a cloud-based platform. The mobile application, running on a user's smartphone or tablet, acts as a central interface for displaying real-time and historical pain data, provides visual feedback on pain trends, and allows the user to enter additional contextual information such as pain triggers or medication use. The application also facilitates remote monitoring by healthcare providers, who can access the data to evaluate the effectiveness of pain management strategies and adjust treatment plans as needed.
[0053] The cloud-based platform stores the data transmitted from the device for long-term analysis. This platform uses advanced data analytics to perform longitudinal analyses, identify pain patterns over time, and gain deeper insights into the effectiveness of treatment plans. The platform can also host a training environment for machine learning models that aggregates anonymized data from multiple users. This aggregated data is used to further refine the machine learning techniques deployed on the NPU and improve their overall accuracy and effectiveness in pain detection and treatment across different patient populations.
[0054] The device's power management system is designed for maximum operating efficiency and battery life. It features a rechargeable battery that allows for up to 48 hours of continuous operation on a single charge. The device is equipped with energy-efficient components and utilizes low-power AI processing to conserve battery power. The device is charged via an inductive charging pad, providing users with convenience and minimizing downtime. The device's exterior surface features a touch-sensitive display that provides users with real-time information on device status, battery life, connectivity, and alerts regarding detected pain events. Additionally, the device incorporates a haptic feedback mechanism that provides tactile alerts, improving user engagement and ensuring timely responses to significant pain episodes.
[0055] The drawings and the foregoing description provide examples of embodiments. Those skilled in the art will recognize that one or more of the described elements may well be combined into a single functional element. Alternatively, certain elements may be separated into multiple functional elements. Elements from one embodiment may be added to another embodiment. For example, orders of the processes described herein may be changed and are not limited to the manner described herein. Furthermore, the actions of any flowchart need not be implemented in the order shown; nor do all actions necessarily need to be performed. Also, those actions that are not dependent on other actions may be performed in parallel with the other actions. The scope of the embodiments is in no way limited by these specific examples.Numerous variations, whether explicitly stated in the specification or not, such as differences in structure, dimensions, and material use, are possible. The scope of the embodiments is at least as broad as indicated in the following claims.
[0056] Advantages, other benefits, and solutions to problems have been described above with reference to specific embodiments. However, the advantages, benefits, solutions to problems, and any components that may cause an advantage or solution to occur or become more apparent are not to be construed as a critical, required, or essential feature or component of any or all of the claims. REFERENCES 100 An intelligent AI-based device for monitoring neuropathic pain. 102 Flexible Portable Structure 102a Sensor arrangement 104 Neural Processing Unit (NPU) 106 Communication module 108 Energy management system 110 Neuromodulationsaktuator
Claims
[1] An intelligent AI-based device for monitoring neuropathic pain, consisting of: a flexible wearable structure made of biocompatible materials, designed to be worn continuously on the user’s body, a sensor array integrated into the structure and configured to collect physiological data from the user's body, the sensor array comprising at least an electrodermal activity (EDA) sensor for measuring skin conductance, an electromyography (EMG) sensor for detecting muscle activity, a heart rate variability (HRV) monitor for evaluating autonomic nervous system responses, and a thermal sensor for measuring skin temperature; a neural processing unit (NPU) housed within the wearable structure, the NPU configured to analyze multidimensional sensor data to detect patterns indicative of the intensity and nature of neuropathic pain; a communication module within the wearable structure that includes Bluetooth Low Energy (BLE) and Wi-Fi connectivity options to enable seamless transfer of processed data to an external device or cloud-based platform; a power management system, including a rechargeable battery integrated into the structure and configured to power the sensor array, the NPU, and the communications module; and a neuromodulation actuator embedded in the wearable structure configured for transcutaneous electrical nerve stimulation (TENS), the actuator enabling on-demand therapeutic intervention based on the detected pain intensity and pattern. [2] The device of claim 1, wherein the flexible wearable structure further comprises an adjustable strap mechanism configured to secure the device to the user's body to ensure optimal skin contact for accurate sensor data acquisition, and wherein the structure is water-resistant to protect the components housed therein from moisture and daily wear and tear. [3] The device of claim 1, wherein the neural processing unit (NPU) is further configured to perform adaptive machine learning techniques that continuously learn from the user's physiological data over time, enabling the device to improve the accuracy of pain detection and personalize pain management recommendations tailored to the user's condition. [4] The device of claim 1, wherein the communication module is configured to transmit processed pain data to a mobile application on a user's smartphone, the mobile application being programmed to display real-time and historical pain measurements, allow the user to enter additional contextual information, and send alerts to healthcare providers to enable remote monitoring and timely intervention. [5] The device of claim 1, wherein the power management system further comprises an energy-efficient circuit design and low-power AI processing capabilities to maximize battery life, and wherein the device includes an integrated haptic feedback mechanism to provide tactile alerts to the user in response to significant pain events detected by the neural processing unit. [6] The device of claim 1, wherein the neuromodulation therapy actuator mechanism is further configured to dynamically adjust the intensity and frequency of the stimulation based on real-time feedback from the sensors and the neural processing unit analysis, thereby providing a personalized therapeutic response tailored to the user's current pain condition. [7] The device of claim 1, wherein the outer surface of the flexible wearable structure includes a touch-sensitive display configured to provide the user with visual feedback on device status, battery life, connectivity, and real-time alerts on detected pain intensity and recommended interventions. [8] The device of claim 1, wherein the sensor array is modular to allow the addition or replacement of specific sensors tailored to the individual needs of the user or specific neuropathic pain conditions, thereby enhancing the versatility and applicability of the device in different clinical scenarios.
Citation Information
Cited By
Pain grading evaluation system based on multi-modal physiological signal fusion
CN120284209A
Cloud-based AI intelligent electrical stimulation system and control method
US20250281735A1
